Log in

A comprehensive catalogue of EQ-5D scores in chronic disease: results of a systematic review

  • Review
  • Published:
Quality of Life Research Aims and scope Submit manuscript

Abstract

Purpose

Chronic diseases are associated with impaired health-related quality of life (HRQoL) outcomes. Comparison of HRQoL outcomes between different diseases and with the general population is of major importance to health economists, epidemiologists, clinicians, and policy makers. The aim of this systematic literature review was to develop a catalogue with EQ-5D scores in chronic non-communicable diseases, and to compare these scores with reference values from the general population.

Methods

MEDLINE, Embase, and Web of Science were systematically searched independently by two reviewers. Studies were included if they reported mean EQ-5D index values for the adult population and if these scores were compared with the general population. The QualSyst tool for quantitative research was used for quality appraisal.

Results

Two hundred and seven articles met the inclusion criteria. An extensive catalogue summarizes the EQ-5D scores in a wide variety of chronic diseases. Mean EQ-5D index values ranged between − 0.20 and 1. Lower EQ-5D scores are reported in chronic diseases compared to the general population, specifically in neurological disorders. Most of the diseases demonstrate a substantial disutility, although a minority of diseases have equal or even higher index scores than the general population.

Conclusion

A comprehensive, international catalogue has been developed to provide EQ-5D index scores for diverse chronic diseases compared with reference values based on the available literature. The catalogue gives a clear overview of the existing EQ-5D scores and can be rapidly accessed by researchers worldwide for different applications such as health economic evaluations, decision making, resource allocation, and other policy objectives. Future studies should focus on unexamined diseases and specific patient groups to expand the evidence base on HRQoL in chronic diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. World Health Organization. (2014). Global status report on noncommunicable diseases 2014. Retrieved August, 1, 2018, from http://apps.who.int/iris/bitstream/handle/10665/148114/9789241564854_eng.pdf;jsessionid=DE930A0A052CB03AB73898D75695E8F7?sequence=1.

  2. World Health Organization. (2013). Global action plan for the prevention and control of noncommunicable diseases 2013–2020. Retrieved August, 1, 2018, from http://apps.who.int/iris/bitstream/handle/10665/94384/9789241506236_eng.pdf?sequence=1.

  3. Megari, K. (2013). Quality of life in chronic disease patients. Health Psychology Research,1(3), e27.

    Article  Google Scholar 

  4. GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. (2018). Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. The Lancet,392(10159), 1789–1858.

    Article  Google Scholar 

  5. Schipper, H., & Olweny, C. (1996). Quality of life studies: definitions and conceptual issues. In B. Spilker (Ed.), Quality of Life and Pharmacoeconomics in Clinical Trials (pp. 11–23). Philadelphia: Lippincott-Raven Publishers.

    Google Scholar 

  6. Grool, A. M., van der Graaf, Y., Visseren, F. L., de Borst, G. J., Algra, A., & Geerlings, M. I. (2012). Self-rated health status as a risk factor for future vascular events and mortality in patients with symptomatic and asymptomatic atherosclerotic disease: The SMART study. Journal of Internal Medicine,272(3), 277–286.

    Article  CAS  Google Scholar 

  7. Spertus, J. A., Jones, P., McDonell, M., Fan, V., & Fihn, S. D. (2002). Health status predicts long-term outcome in outpatients with coronary disease. Circulation,106(1), 43–49.

    Article  Google Scholar 

  8. Mapes, D. L., Lopes, A. A., Satayathum, S., McCullough, K. P., Goodkin, D. A., Locatelli, F., et al. (2003). Health-related quality of life as a predictor of mortality and hospitalization: The Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney International,64(1), 339–349.

    Article  Google Scholar 

  9. Kind, P., Lafata, J. E., Matuszewski, K., & Raisch, D. (2009). The use of QALYs in clinical and patient decision-making: Issues and prospects. Value Health,12(Suppl 1), S27–S30.

    Article  Google Scholar 

  10. Ko, Y., & Coons, S. J. (2006). Self-reported chronic conditions and EQ-5D index scores in the US adult population. Current Medical Research and Opinion,22(10), 2065–2071.

    Article  Google Scholar 

  11. Whitehead, S. J., & Ali, S. (2010). Health outcomes in economic evaluation: The QALY and utilities. British Medical Bulletin,96, 5–21.

    Article  Google Scholar 

  12. Kang, E. J., & Ko, S. K. (2009). A catalogue of EQ-5D utility weights for chronic diseases among noninstitutionalized community residents in Korea. Value Health,12(Suppl 3), S114–S117.

    Article  Google Scholar 

  13. Dolan, P. (1997). Modeling valuations for EuroQol health states. Medical Care,35(11), 1095–1108.

    Article  CAS  Google Scholar 

  14. Group, T. E. (1990). EuroQol—A new facility for the measurement of health-related quality of life. Health Policy,16(3), 199–208.

    Article  Google Scholar 

  15. Sullivan, P. W., Slejko, J. F., Sculpher, M. J., & Ghushchyan, V. (2011). Catalogue of EQ-5D scores for the United Kingdom. Medical Decision Making,31(6), 800–804.

    Article  Google Scholar 

  16. Dyer, M. T., Goldsmith, K. A., Sharples, L. S., & Buxton, M. J. (2010). A review of health utilities using the EQ-5D in studies of cardiovascular disease. Health and Quality of Life Outcomes,8, 13.

    Article  Google Scholar 

  17. Sassi, F. (2006). Calculating QALYs, comparing QALY and DALY calculations. Health Policy Plan,21(5), 402–408.

    Article  Google Scholar 

  18. JPT, H. (2011). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration. Retrieved April, 24, 2018, from www.handbook.cochrane.org.

  19. McGowan, J., Sampson, M., Salzwedel, D. M., Cogo, E., Foerster, V., & Lefebvre, C. (2016). PRESS peer review of electronic search strategies: 2015 Guideline Statement. Journal of Clinical Epidemiology,75, 40–46.

    Article  Google Scholar 

  20. Kmet, L. M., & Cook, L. S. (2004). Standard quality assessment criteria for evaluating primary research papers from a variety of fields. Alberta Heritage Foundation for Medical Research (AHFMR),2011, 1–22.

    Google Scholar 

  21. Bramer, G. R. (1988). International statistical classification of diseases and related health problems. Tenth revision. World Health Stat Q,41(1), 32–36.

    CAS  PubMed  Google Scholar 

  22. Devlin, N. J., & Brooks, R. (2017). EQ-5D and the EuroQol Group: Past, present and future. Applied Health Economics and Health Policy,15(2), 127–137.

    Article  Google Scholar 

  23. National Institute for Health and Clinical Excellence (NICE). (2013). Guide to the Methods of Technology Appraisal. London: NICE.

    Google Scholar 

  24. Cohen, R. D. (2002). The quality of life in patients with Crohn’s disease. Alimentary Pharmacology & Therapeutics,16(9), 1603–1609.

    Article  CAS  Google Scholar 

  25. de Jong, W., Kaptein, A. A., van der Schans, C. P., Mannes, G. P., van Aalderen, W. M., Grevink, R. G., et al. (1997). Quality of life in patients with cystic fibrosis. Pediatric Pulmonology,23(2), 95–100.

    Article  Google Scholar 

  26. Coman, A. C., Borzan, C., Vesa, C. S., & Todea, D. A. (2016). Obstructive sleep apnea syndrome and the quality of life. Clujul Medical,89(3), 390.

    PubMed  PubMed Central  Google Scholar 

  27. Muller-Nordhorn, J., Roll, S., Bohmig, M., Nocon, M., Reich, A., Braun, C., et al. (2006). Health-related quality of life in patients with pancreatic cancer. Digestion,74(2), 118–125.

    Article  CAS  Google Scholar 

  28. van der Have, M., van der Aalst, K. S., Kaptein, A. A., Leenders, M., Siersema, P. D., Oldenburg, B., et al. (2014). Determinants of health-related quality of life in Crohn’s disease: A systematic review and meta-analysis. J Crohns Colitis,8(2), 93–106.

    Article  Google Scholar 

  29. Zhao, C., Wong, L., Zhu, Q., & Yang, H. (2018). Prevalence and correlates of chronic diseases in an elderly population: A community-based survey in Haikou. PLoS ONE,13(6), e0199006.

    Article  Google Scholar 

  30. Wolff, J. L., Starfield, B., & Anderson, G. (2002). Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Archives of Internal Medicine,162(20), 2269–2276.

    Article  Google Scholar 

  31. Sullivan, P. W., Lawrence, W. F., & Ghushchyan, V. (2005). A national catalog of preference-based scores for chronic conditions in the United States. Medical Care,43(7), 736–749.

    Article  Google Scholar 

  32. Cherepanov, D., Palta, M., Fryback, D. G., & Robert, S. A. (2010). Gender differences in health-related quality-of-life are partly explained by sociodemographic and socioeconomic variation between adult men and women in the US: Evidence from four US nationally representative data sets. Quality of Life Research,19(8), 1115–1124.

    Article  Google Scholar 

  33. Kind, P., Dolan, P., Gudex, C., & Williams, A. (1998). Variations in population health status: Results from a United Kingdom national questionnaire survey. BMJ,316(7133), 736–741.

    Article  CAS  Google Scholar 

  34. Hajian-Tilaki, K., Heidari, B., & Hajian-Tilaki, A. (2017). Are gender differences in health-related quality of life attributable to sociodemographic characteristics and chronic disease conditions in elderly people? Int J Prev Med,8, 95.

    PubMed  PubMed Central  Google Scholar 

  35. Saarni, S. I., Harkanen, T., Sintonen, H., Suvisaari, J., Koskinen, S., Aromaa, A., et al. (2006). The impact of 29 chronic conditions on health-related quality of life: A general population survey in Finland using 15D and EQ-5D. Quality of Life Research,15(8), 1403–1414.

    Article  Google Scholar 

  36. Wailoo, A., Hernandez Alava, M., Grimm, S., Pudney, S., Gomes, M., & Sadique, Z. (2017). Comparing the EQ-5D-3L and 5L versions. What are the implications for cost effectiveness estimates?

  37. Subramaniam, M., Soh, P., Vaingankar, J. A., Picco, L., & Chong, S. A. (2013). Quality of life in obsessive-compulsive disorder: Impact of the disorder and of treatment. CNS Drugs,27(5), 367–383.

    Article  Google Scholar 

  38. Shrive, F. M., Ghali, W. A., Johnson, J. A., Donaldson, C., & Manns, B. J. (2007). Use of the U.S. and U.K. scoring algorithm for the EuroQol-5D in an economic evaluation of cardiac care. Medical Care,45(3), 269–273.

    Article  Google Scholar 

  39. Tengs, T. O., & Wallace, A. (2000). One thousand health-related quality-of-life estimates. Medical Care,38(6), 583–637.

    Article  CAS  Google Scholar 

  40. Zhao, Y., Li, S. P., Liu, L., Zhang, J. L., & Chen, G. (2017). Does the choice of tariff matter? A comparison of EQ-5D-5L utility scores using Chinese, UK, and Japanese tariffs on patients with psoriasis vulgaris in Central South China. Medicine (Baltimore),96(34), e7840.

    Article  Google Scholar 

  41. Dolan, P. (1997). Aggregating health state valuations. J Health Serv Res Policy,2(3), 160–165. (discussion 166–167).

    Article  CAS  Google Scholar 

  42. De Smedt, D., Clays, E., Annemans, L., & De Bacquer, D. (2014). EQ-5D versus SF-12 in coronary patients: Are they interchangeable? Value Health,17(1), 84–89.

    Article  Google Scholar 

Download references

Funding

This study was funded by a Grant from Ghent University (Grant No. 01N02618) (Bijzonder Onderzoeksfonds, BOF).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lisa Van Wilder.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Van Wilder, L., Rammant, E., Clays, E. et al. A comprehensive catalogue of EQ-5D scores in chronic disease: results of a systematic review. Qual Life Res 28, 3153–3161 (2019). https://doi.org/10.1007/s11136-019-02300-y

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11136-019-02300-y

Keywords

Navigation